SQZ Biotechnologies Co (SQZB)
0.021
0.00 (0.00%)
USD |
OTCM |
May 17, 15:23
SQZ Biotechnologies Total Liabilities (Quarterly): 29.61M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 29.61M |
| March 31, 2023 | 33.00M |
| December 31, 2022 | 42.75M |
| September 30, 2022 | 86.28M |
| June 30, 2022 | 92.12M |
| March 31, 2022 | 95.88M |
| December 31, 2021 | 102.18M |
| Date | Value |
|---|---|
| September 30, 2021 | 110.87M |
| June 30, 2021 | 85.85M |
| March 31, 2021 | 93.59M |
| December 31, 2020 | 103.94M |
| September 30, 2020 | 281.13M |
| June 30, 2020 | 95.78M |
| December 31, 2019 | 225.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.61M
Minimum
Jun 2023
281.13M
Maximum
Sep 2020
105.63M
Average
94.68M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.15M |
| Shareholders Equity (Quarterly) | 24.54M |
| Current Ratio | 2.793 |